Human Immunodeficiency Virus Preexposure Prophylaxis: Meeting the Needs of Transgender Populations

被引：2
作者：
Krakower, Douglas S. [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Div Infect Dis, 110 Francis St, Boston, MA 02215 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2021年 / 73卷 / 07期
关键词：
HIV; HIV prevention; preexposure prophylaxis; transgender populations; clinical pharmacology;
D O I：
10.1093/cid/ciaa1158
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E2124 / E2126
页数：3
相关论文
共 11 条
  • [1] Estimating the Prevalence of HIV and Sexual Behaviors Among the US Transgender Population: A Systematic Review and Meta-Analysis, 2006-2017
    Becasen, Jeffrey S.
    Denard, Christa L.
    Mullins, Mary M.
    Higa, Darrel H.
    Sipe, Theresa Ann
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2019, 109 (01) : E1 - E8
  • [2] Cespedes MS, 2020, C RETR OPP INF 8 11
  • [3] Decreased Tenofovir Diphosphate Concentrations in a Transgender Female Cohort: Implications for Human Immunodeficiency Virus Preexposure Prophylaxis
    Cottrell, Mackenzie L.
    Prince, Heather M. A.
    Schauer, Amanda P.
    Sykes, Craig
    Maffuid, Kaitlyn
    Poliseno, Amanda
    Chun, Tae-Wook
    Huiting, Erin
    Stanczyk, Frank Z.
    Peery, Anne F.
    Dellon, Evan S.
    Adams, Jessica L.
    Gay, Cindy
    Kashuba, Angela D. M.
    [J]. CLINICAL INFECTIOUS DISEASES, 2019, 69 (12) : 2201 - 2204
  • [4] Grinsztejn B, 2020, J INT AIDS SOC, V23, P174
  • [5] Drug-drug interactions between feminizing hormone therapy and pre-exposure prophylaxis among transgender women: the iFACT study
    Hiransuthikul, Akarin
    Janamnuaysook, Rena
    Himmad, Kanittha
    Kerr, Stephen J.
    Thammajaruk, Narukjaporn
    Pankam, Tippawan
    Phanjaroen, Kannapat
    Mills, Stephen
    Vannakit, Ravipa
    Phanuphak, Praphan
    Phanuphak, Nittaya
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 (07)
  • [6] Landovitz RJ, 2020, J INT AIDS SOC, V23, P183
  • [7] Mayer KH, 2020, LANCET, V396, P239, DOI 10.1016/S0140-6736(20)31065-5
  • [8] Strategies for engaging transgender populations in HIV prevention and care
    Poteat, Tonia
    Wirtz, Andrea L.
    Reisner, Sari
    [J]. CURRENT OPINION IN HIV AND AIDS, 2019, 14 (05) : 393 - 400
  • [9] Transgender women on oral HIV pre-exposure prophylaxis have significantly lower tenofovir and emtricitabine concentrations when also taking oestrogen when compared to cisgender men
    Shieh, Eugenie
    Marzinke, Mark A.
    Fuchs, Edward J.
    Hamlin, Allyson
    Bakshi, Rahul
    Aung, Wutyi
    Breakey, Jennifer
    Poteat, Tonia
    Brown, Todd
    Bumpus, Namandje N.
    Hendrix, Craig W.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 (11)
  • [10] White Hughto Jaclyn M, 2016, Transgend Health, V1, P21
12